Accustem Sciences Inc
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to … Read more
Market Cap & Net Worth: Accustem Sciences Inc (ACUT)
Accustem Sciences Inc (OTCQB:ACUT) has a market capitalization of $6.59 Million ($6.59 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #31517 globally and #10371 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Accustem Sciences Inc's stock price $0.41 by its total outstanding shares 16072267 (16.07 Million).
Accustem Sciences Inc Market Cap History: 2022 to 2025
Accustem Sciences Inc's market capitalization history from 2022 to 2025. Data shows change from $21.70 Million to $6.59 Million (-40.31% CAGR).
Accustem Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Accustem Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ACUT by Market Capitalization
Companies near Accustem Sciences Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Accustem Sciences Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Accustem Sciences Inc Historical Marketcap From 2022 to 2025
Between 2022 and today, Accustem Sciences Inc's market cap moved from $21.70 Million to $ 6.59 Million, with a yearly change of -40.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.59 Million | +13.89% |
| 2024 | $5.79 Million | -42.46% |
| 2023 | $10.06 Million | -53.65% |
| 2022 | $21.70 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Accustem Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.59 Million USD |
| MoneyControl | $6.59 Million USD |
| MarketWatch | $6.59 Million USD |
| marketcap.company | $6.59 Million USD |
| Reuters | $6.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.